Shopping Cart 0
Cart Subtotal
AED 0

Boehringer Ingelheim International GmbH - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Boehringer Ingelheim International GmbH-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

Boehringer Ingelheim International GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG, is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biopharmaceuticals. The company's products are used in the treatment of central nervous system disorders, respiratory diseases, cardiovascular diseases, metabolic disorders, cancer, urological and viral conditions, among others. It operates facilities for manufacture pharmaceuticals, chemical active substances, and medical products. Boehringer operates globally through affiliates and is headquartered in Ingelheim am Rhein, Rheinland-Pfalz, Germany.

Boehringer Ingelheim International GmbH Key Recent Developments

Jun 03,2019: Boehringer Ingelheim and PharmAccess launch digital healthcare program in Kenya

May 31,2019: Boehringer collaborates with Gubra for obesity treatments

May 23,2019: Network of 1,500 stroke-ready clinics across Europe

May 14,2019: Digital transformation: Boehringer Ingelheim fosters cooperation with innovative partners

Apr 18,2019: Boehringer partners PureTech to develop immuno-oncology candidates

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Boehringer Ingelheim International GmbH-Key Facts

Boehringer Ingelheim International GmbH-Key Employees

Boehringer Ingelheim International GmbH-Key Employee Biographies

Boehringer Ingelheim International GmbH-Major Products and Services

Boehringer Ingelheim International GmbH-History

Boehringer Ingelheim International GmbH-Company Statement

Boehringer Ingelheim International GmbH-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Boehringer Ingelheim International GmbH-Business Description

Business Segment: Animal Health

Overview

Performance

Business Segment: Biopharmaceuticals

Overview

Performance

Key Stats

Business Segment: Human Pharmaceuticals

Overview

Performance

Business Segment: Other Sales

Overview

Performance

Geographical Segment: Asia/Australia/Africa

Performance

Geographical Segment: Europe

Performance

Geographical Segment: The Americas

Performance

R&D Overview

Boehringer Ingelheim International GmbH-Corporate Strategy

Boehringer Ingelheim International GmbH-SWOT Analysis

SWOT Analysis-Overview

Boehringer Ingelheim International GmbH-Strengths

Boehringer Ingelheim International GmbH-Weaknesses

Boehringer Ingelheim International GmbH-Opportunities

Boehringer Ingelheim International GmbH-Threats

Boehringer Ingelheim International GmbH-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Recent Deals Summary

Section 4-Company's Recent Developments

Jun 03, 2019: Boehringer Ingelheim and PharmAccess launch digital healthcare program in Kenya

May 31, 2019: Boehringer collaborates with Gubra for obesity treatments

May 23, 2019: Network of 1,500 stroke-ready clinics across Europe

May 14, 2019: Digital transformation: Boehringer Ingelheim fosters cooperation with innovative partners

Apr 18, 2019: Boehringer partners PureTech to develop immuno-oncology candidates

Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests

Feb 25, 2019: Boehringer Ingelheim: New chief medical officer appointed

Feb 12, 2019: Boehringer Ingelheim (Canada) and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials

Jan 17, 2019: Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities

Jan 08, 2019: Adimab provides year-end update on 2018 partnership activities

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Boehringer Ingelheim International GmbH, Key Facts

Boehringer Ingelheim International GmbH, Key Employees

Boehringer Ingelheim International GmbH, Key Employee Biographies

Boehringer Ingelheim International GmbH, Major Products and Services

Boehringer Ingelheim International GmbH, History

Boehringer Ingelheim International GmbH, Other Locations

Boehringer Ingelheim International GmbH, Subsidiaries

Boehringer Ingelheim International GmbH, Key Competitors

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Boehringer Ingelheim International GmbH, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Phibro Animal Health Corp

Pfizer Inc

Novartis AG

Jurgen Schmidt Chemievertretung GmbH

F. Hoffmann-La Roche Ltd

Eli Lilly and Co

Bristol-Myers Squibb Co

Company Profile

Company Profile Title

Boehringer Ingelheim International GmbH-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

Boehringer Ingelheim International GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG, is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biopharmaceuticals. The company's products are used in the treatment of central nervous system disorders, respiratory diseases, cardiovascular diseases, metabolic disorders, cancer, urological and viral conditions, among others. It operates facilities for manufacture pharmaceuticals, chemical active substances, and medical products. Boehringer operates globally through affiliates and is headquartered in Ingelheim am Rhein, Rheinland-Pfalz, Germany.

Boehringer Ingelheim International GmbH Key Recent Developments

Jun 03,2019: Boehringer Ingelheim and PharmAccess launch digital healthcare program in Kenya

May 31,2019: Boehringer collaborates with Gubra for obesity treatments

May 23,2019: Network of 1,500 stroke-ready clinics across Europe

May 14,2019: Digital transformation: Boehringer Ingelheim fosters cooperation with innovative partners

Apr 18,2019: Boehringer partners PureTech to develop immuno-oncology candidates

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Boehringer Ingelheim International GmbH-Key Facts

Boehringer Ingelheim International GmbH-Key Employees

Boehringer Ingelheim International GmbH-Key Employee Biographies

Boehringer Ingelheim International GmbH-Major Products and Services

Boehringer Ingelheim International GmbH-History

Boehringer Ingelheim International GmbH-Company Statement

Boehringer Ingelheim International GmbH-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Boehringer Ingelheim International GmbH-Business Description

Business Segment: Animal Health

Overview

Performance

Business Segment: Biopharmaceuticals

Overview

Performance

Key Stats

Business Segment: Human Pharmaceuticals

Overview

Performance

Business Segment: Other Sales

Overview

Performance

Geographical Segment: Asia/Australia/Africa

Performance

Geographical Segment: Europe

Performance

Geographical Segment: The Americas

Performance

R&D Overview

Boehringer Ingelheim International GmbH-Corporate Strategy

Boehringer Ingelheim International GmbH-SWOT Analysis

SWOT Analysis-Overview

Boehringer Ingelheim International GmbH-Strengths

Boehringer Ingelheim International GmbH-Weaknesses

Boehringer Ingelheim International GmbH-Opportunities

Boehringer Ingelheim International GmbH-Threats

Boehringer Ingelheim International GmbH-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Recent Deals Summary

Section 4-Company's Recent Developments

Jun 03, 2019: Boehringer Ingelheim and PharmAccess launch digital healthcare program in Kenya

May 31, 2019: Boehringer collaborates with Gubra for obesity treatments

May 23, 2019: Network of 1,500 stroke-ready clinics across Europe

May 14, 2019: Digital transformation: Boehringer Ingelheim fosters cooperation with innovative partners

Apr 18, 2019: Boehringer partners PureTech to develop immuno-oncology candidates

Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests

Feb 25, 2019: Boehringer Ingelheim: New chief medical officer appointed

Feb 12, 2019: Boehringer Ingelheim (Canada) and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials

Jan 17, 2019: Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities

Jan 08, 2019: Adimab provides year-end update on 2018 partnership activities

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Boehringer Ingelheim International GmbH, Key Facts

Boehringer Ingelheim International GmbH, Key Employees

Boehringer Ingelheim International GmbH, Key Employee Biographies

Boehringer Ingelheim International GmbH, Major Products and Services

Boehringer Ingelheim International GmbH, History

Boehringer Ingelheim International GmbH, Other Locations

Boehringer Ingelheim International GmbH, Subsidiaries

Boehringer Ingelheim International GmbH, Key Competitors

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Boehringer Ingelheim International GmbH, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Boehringer Ingelheim International GmbH, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Phibro Animal Health Corp

Pfizer Inc

Novartis AG

Jurgen Schmidt Chemievertretung GmbH

F. Hoffmann-La Roche Ltd

Eli Lilly and Co

Bristol-Myers Squibb Co